二氢神经酰胺去饱和酶 1(DES1)主要位于内质网,通过引入 4,5-反式双键催化二氢神经酰胺转化为神经酰胺。二氢神经酰胺去饱和酶 1 促进神经酰胺合成和鞘脂代谢,诱导细胞凋亡和自噬,调节内质网应激。二氢神经酰胺去饱和酶 1 功能障碍可导致神经酰胺异常积累,从而影响胰岛素信号传导,导致胰岛素抵抗和脂肪肝。二氢神经酰胺脱氢酶 1 还会导致癌症或一些神经系统疾病[1]。
Dihydroceramide Desaturase 1 (DES1) is mainly located in the endoplasmic reticulum, and catalyzes the conversion of dihydroceramide to ceramide through introduction of a 4,5-trans double bond. Dihydroceramide Desaturase 1 promotes the ceramide synthesis and sphingolipid metabolism, induces the cell apoptosis and autophagy, and regulates endoplasmic reticulum stress. Dihydroceramide Desaturase 1 dysfunction could cause ceramide abnormal accumulation, thereby affecting insulin signaling, leading to insulin resistance and fatty liver. Dihydroceramide Desaturase 1 also causes cancer or some neurological disorders[1].
(1R,2S)-Deoxy-PR280 是一种二氢神经酰胺去饱和酶 (dihydroceramide desaturase) 的竞争性抑制剂,其 Ki 值为 6 µM。
GAA-4OH 是一种强效且不可逆的二氢神经酰胺去饱和酶-1 (DES1) 抑制剂,其 IC50 为 0.6 μM、Ki 为 139.5 nM,可通过氧化反应生成活性亚氨基醌,后者共价阻断 DES1 的催化腔而导致酶永久失活,并通过降低肝组织中神经酰胺与二氢神经酰胺的比例来调节鞘脂平衡,从而改善肝脏脂肪变性、炎症和纤维化,降低促炎和促纤维化基因的表达,可用于代谢功能障碍相关脂肪性肝病 (MASLD) 的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号